BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29431141)

  • 1. Does tranexamic acid lead to changes in MRI measures of brain tissue health in patients with spontaneous intracerebral haemorrhage? Protocol for a MRI substudy nested within the double-blind randomised controlled TICH-2 trial.
    Dineen RA; Pszczolkowski S; Flaherty K; Law ZK; Morgan PS; Roberts I; Werring DJ; Al-Shahi Salman R; England T; Bath PM; Sprigg N
    BMJ Open; 2018 Feb; 8(2):e019930. PubMed ID: 29431141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Tranexamic Acid Administration on Remote Cerebral Ischemic Lesions in Acute Spontaneous Intracerebral Hemorrhage: A Substudy of a Randomized Clinical Trial.
    Pszczolkowski S; Sprigg N; Woodhouse LJ; Gallagher R; Swienton D; Law ZK; Casado AM; Roberts I; Werring DJ; Al-Shahi Salman R; England TJ; Morgan PS; Bath PM; Dineen RA
    JAMA Neurol; 2022 May; 79(5):468-477. PubMed ID: 35311937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
    Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM
    Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical analysis plan for the 'Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage' (TICH-2) trial.
    Flaherty K; Bath PM; Dineen R; Law Z; Scutt P; Pocock S; Sprigg N;
    Trials; 2017 Dec; 18(1):607. PubMed ID: 29262841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of haematoma progression by tranexamic acid in intracerebral haemorrhage patients with and without spot sign on admission scan: a statistical analysis plan of a pre-specified sub-study of the TICH-2 trial.
    Ovesen C; Jakobsen JC; Gluud C; Steiner T; Law Z; Flaherty K; Dineen RA; Bath PM; Sprigg N; Christensen H
    BMC Res Notes; 2018 Jun; 11(1):379. PubMed ID: 29895329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.
    Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Christensen H; Ciccone A; Collins R; Czlonkowska A; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Krishnan K; Laska AC; Law ZK; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Seiffge D; Scutt P; Thanabalan J; Werring D; Whynes D; Bath PM;
    Lancet; 2018 May; 391(10135):2107-2115. PubMed ID: 29778325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial.
    Meretoja A; Yassi N; Wu TY; Churilov L; Sibolt G; Jeng JS; Kleinig T; Spratt NJ; Thijs V; Wijeratne T; Cho DY; Shah D; Cloud GC; Phan T; Bladin C; Moey A; Aviv RI; Barras CD; Sharma G; Hsu CY; Ma H; Campbell BCV; Mitchell P; Yan B; Parsons MW; Tiainen M; Curtze S; Strbian D; Tang SC; Harvey J; Levi C; Donnan GA; Davis SM
    Lancet Neurol; 2020 Dec; 19(12):980-987. PubMed ID: 33128912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and Design of a Randomized, Double-Blind Trial Evaluating the Efficacy of Tranexamic Acid on Hematoma Expansion and Peri-hematomal Edema in Patients with Spontaneous Intracerebral Hemorrhage within 4.5 h after Symptom Onset: The THE-ICH Trial Protocol.
    Jiang C; Wang J; Wang J; Zhang J;
    J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105136. PubMed ID: 32912508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial.
    Yassi N; Zhao H; Churilov L; Wu TY; Ma H; Nguyen HT; Cheung A; Meretoja A; Mai DT; Kleinig T; Jeng JS; Choi PMC; Duc PD; Brown H; Ranta A; Spratt N; Cloud GC; Wang HK; Grimley R; Mahawish K; Cho DY; Shah D; Nguyen TMP; Sharma G; Yogendrakumar V; Yan B; Harrison EL; Devlin M; Cordato D; Martinez-Majander N; Strbian D; Thijs V; Sanders LM; Anderson D; Parsons MW; Campbell BCV; Donnan GA; Davis SM;
    Lancet Neurol; 2024 Jun; 23(6):577-587. PubMed ID: 38648814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nested mechanistic sub-study into the effect of tranexamic acid versus placebo on intracranial haemorrhage and cerebral ischaemia in isolated traumatic brain injury: study protocol for a randomised controlled trial (CRASH-3 Trial Intracranial Bleeding Mechanistic Sub-Study [CRASH-3 IBMS]).
    Mahmood A; Roberts I; Shakur H
    Trials; 2017 Jul; 18(1):330. PubMed ID: 28716153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranexamic Acid for Prevention of Hematoma Expansion in Intracerebral Hemorrhage Patients With or Without Spot Sign.
    Ovesen C; Jakobsen JC; Gluud C; Steiner T; Law Z; Flaherty K; Dineen RA; Christensen LM; Overgaard K; Rasmussen RS; Bath PM; Sprigg N; Christensen H
    Stroke; 2021 Aug; 52(8):2629-2636. PubMed ID: 34000834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: Protocol for a randomized, placebo-controlled trial.
    Sprigg N; Robson K; Bath P; Dineen R; Roberts I; Robinson T; Roffe C; Werring D; Al-Shahi Salman R; Pocock S; Duley L; England T; Whynes D; Ciccone A; Laska AC; Christensen H; Ozturk S; Collins R; Bereczki D; Egea-Guerrero JJ; Law ZK; Czlonkowska A; Seiffge D; Beredzie M;
    Int J Stroke; 2016 Aug; 11(6):683-94. PubMed ID: 27048694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury--a nested randomised, placebo-controlled trial.
    Perel P; Al-Shahi Salman R; Kawahara T; Morris Z; Prieto-Merino D; Roberts I; Sandercock P; Shakur H; Wardlaw J
    Health Technol Assess; 2012; 16(13):iii-xii, 1-54. PubMed ID: 22417901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tranexamic acid on intracranial haemorrhage and infarction in patients with traumatic brain injury: a pre-planned substudy in a sample of CRASH-3 trial patients.
    Mahmood A; Needham K; Shakur-Still H; Harris T; Jamaluddin SF; Davies D; Belli A; Mohamed FL; Leech C; Lotfi HM; Moss P; Lecky F; Hopkins P; Wong D; Boyle A; Wilson M; Darwent M; Roberts I
    Emerg Med J; 2021 Apr; 38(4):270-278. PubMed ID: 33262252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerance of early administration of tranexamic acid in patients with cirrhosis presenting with acute upper gastrointestinal bleeding: a study protocol for a multicentre, randomised, double-blind, placebo-controlled trial (the EXARHOSE study).
    Heidet M; Amathieu R; Audureau E; Augusto O; Nicolazo de Barmon V; Rialland A; Schmitz D; Pierrang F; Marty J; Chollet-Xémard C; Thirion O; Jacob L
    BMJ Open; 2018 Aug; 8(8):e021943. PubMed ID: 30099397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trial.
    Yassi N; Zhao H; Churilov L; Campbell BCV; Wu T; Ma H; Cheung A; Kleinig T; Brown H; Choi P; Jeng JS; Ranta A; Wang HK; Cloud GC; Grimley R; Shah D; Spratt N; Cho DY; Mahawish K; Sanders L; Worthington J; Clissold B; Meretoja A; Yogendrakumar V; Ton MD; Dang DP; Phuong NTM; Nguyen HT; Hsu CY; Sharma G; Mitchell PJ; Yan B; Parsons MW; Levi C; Donnan GA; Davis SM
    Stroke Vasc Neurol; 2022 Apr; 7(2):158-165. PubMed ID: 34848566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: study protocol for an international, randomised, double-blind, placebo-controlled trial.
    Ker K; Roberts I; Chaudhri R; Fawole B; Beaumont D; Balogun E; Prowse D; Pepple T; Javaid K; Kayani A; Arulkumaran S; Bates I; Shakur-Still H;
    Trials; 2018 Dec; 19(1):712. PubMed ID: 30594227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial protocol: preoperative administration of tranexamic acid in sleeve gastrectomy (PATAS) to reduce haemorrhage rates. A randomised controlled trial.
    Leeman M; Huisbrink J; Wijnand JMA; Biter LU; Verbrugge SJC; Dunkelgrun M; Apers JA
    BMJ Open; 2020 Feb; 10(2):e034572. PubMed ID: 32029498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of tranexamic acid in paediatric cardiac surgery: study protocol for a double-blind randomised controlled trial.
    Zhang Y; Jia Y; Shi J; Yuan S; Wang R; Zhang Z; Wang X; Liu J; Ran J; Zhao Y; Hua Z; Yan J; Li S; Zheng Z; Hu S; Wang Y; Yan F
    BMJ Open; 2019 Nov; 9(11):e032642. PubMed ID: 31772102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial.
    Shakur H; Elbourne D; Gülmezoglu M; Alfirevic Z; Ronsmans C; Allen E; Roberts I
    Trials; 2010 Apr; 11():40. PubMed ID: 20398351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.